Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-06-04

FDA Approved: ATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRIC — Supplemental Application (Glenmark Pharmaceuticals Inc.,USA)

View source ↗

Summary

FDA supplemental approval adds pediatric labeling for atovaquone and proguanil hydrochloride, expanding its use to pediatric patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATIC (atovaquone and proguanil hydrochloride)

Snippet

SUPPL AP for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRIC (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRIC)